PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $506,000 | -92.3% | 21,936 | -96.6% | 0.00% | -100.0% |
| Q3 2020 | $6,535,000 | +18.9% | 641,906 | +74.0% | 0.00% | 0.0% |
| Q2 2020 | $5,497,000 | +486.7% | 368,904 | +380.3% | 0.00% | – |
| Q1 2020 | $937,000 | +354.9% | 76,808 | +492.6% | 0.00% | – |
| Q4 2019 | $206,000 | +288.7% | 12,961 | +201.0% | 0.00% | – |
| Q3 2019 | $53,000 | -68.1% | 4,306 | -65.7% | 0.00% | – |
| Q2 2019 | $166,000 | – | 12,538 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|